No Picture
News

Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commercial Applications

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today introduced the Gibco CTS AAV-MAX Helper-Free AAV Production System, a new all-in-one solution designed to help meet clinical and commercial demands for cost-effective […]

No Picture
News

Biocept Announces Participation in an Investigator-Initiated Study to Better Understand the Development and Progression of Metastatic Breast Cancer to the Central Nervous System

SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces a collaboration agreement to participate in an investigator-initiated, non-therapeutic pilot study to evaluate the cerebrospinal fluid tumor and […]

No Picture
News

OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanoma

PENNINGTON, N.J. and SAN DIEGO, Nov. 15, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical stage biotechnology company developing intratumoral immunotherapies that stimulate the patient’s immune system to target […]

No Picture
News

Syncell to Present at SfN’s Neuroscience 2022 Event

SAN DIEGO–(BUSINESS WIRE)– #cancerresearch–Syncell Inc., a life science company revolutionizing spatial biology research, will showcase its innovative spatial proteomics system, Microscoop™, at the Society for Neuroscience’s (SfN) annual meeting in San Diego on November 12-16, […]

No Picture
News

Equillium Announces Data Suggesting Soluble ALCAM as a Potential Biomarker of Disease Severity in Lupus Nephritis at ACR Convergence 2022

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that a poster presentation […]

No Picture
News

Ionis presents positive Phase 2 data from open label extension study of donidalorsen at 2022 ACAAI Annual Meeting

– Interim results show sustained reduction in hereditary angioedema attacks and no new safety signals in patients treated for one year CARLSBAD, Calif., Nov. 13, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented […]

No Picture
News

OncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment

PENNINGTON, N.J. and SAN DIEGO, Nov. 11, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company developing intratumoral immunotherapies that stimulate the patient’s immune system to target cancer […]

No Picture
News

Manufacturing roundup: Alcami acquired by capital groups; Wheeler Bio starts on new manufacturing site in Oklahoma

Two investment groups have come together to purchase the CDMO Alcami. Global Healthcare Opportunities, otherwise known as GHO Capital, and The Vistra Group joined to acquire a controlling interest in the Alcami Corporation from funds […]

No Picture
News

Biological Dynamics, an early detection disease management company, expands leadership

Company prepares for commercialization, continued ExoVerita™ platform development and funding SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Biological Dynamics, an exosome isolation technology and early disease detection company, today announced new executive appointments to fuel […]